Nektar Therapeutics
NKTR
NKTR
180 hedge funds and large institutions have $732M invested in Nektar Therapeutics in 2025 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
16% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 43
9.35% more ownership
Funds ownership: 75.78% → 85.14% (+9.4%)
11% less capital invested
Capital invested by funds: $820M → $732M (-$88M)
Holders
180
Holding in Top 10
5
Calls
$36.6M
Puts
$26.8M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$31M | |
| 3 | +$18.4M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$17.9M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$17.9M |
Top Sellers
| 1 | -$45M | |
| 2 | -$30.3M | |
| 3 | -$20.3M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$17.1M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$10.7M |
